Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Companies

Companies

Displaying 1..10 of 19 - per page Next page
Order by
Mundipharma International seeks products in analgesia, anesthesia and oncology to market through a pan-European sales force. More
Supernus Pharmaceuticals is a specialty pharmaceutical company specific expertise in developing differentiated products in collaboration with partners and for its own CNS product portfolio. More
Valeant Pharmaceuticals is a US based specialty company with capabilities from R&D through Manufacturing and Sales and Marketing in all major world markets. More
GW Pharmaceuticals develops a range of medicines based on cannabinoids and other controlled drugs More
Amarin Corporation plc is a neuroscience company focused on the development and commercialization of novel drugs for the treatment of CNS disorders More
Elan Corporation, plc, headquartered in Dublin, Ireland, is a leading world-wide drug delivery and speciality biopharmaceutical company. More
Fully integrated global CNS pharmaceutical company More
Product development for cancer, inflammation, and neurodegenerative disease More
Farmacija is a pharmaceutical company focusing on the discovery and development of innovative peptide-based drugs, primarily for the treatment of auto-immune and inflammatory diseases. More
Displaying 1..10 of 19 - per page Next page
Order by

Your selection

Therapeutic target
Central Nervous System del
Neurodegenerative disorders del
Multiple sclerosis del

Browse By

Partnering consultation free of charge
Pharma Business Strategies for Biomarkers
Stem Cell Conference
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us